-------------------------------------------------
-------
IACM-Bulletin of 17 March 2010
-------------------------------- ------------------------
* Science: a pilot study, the medical use of cannabis
not affect the results of treatment for abuse
substance
1.
Science: a pilot study, the medical use of cannabis
not affect the results of treatment for substance abuse
has investigated the effects of medical use of cannabis in the
result of treatment for abuse of
substances in a pilot study conducted in California. Of the members,
raised a public program for substance abuse treatment in California
, 13 medical cannabis and 146 no.
all medical cannabis users were included in the
treatment program for substance abuse
judicial order and had received permission to use cannabis for therapeutic purposes
while in the program.
The researchers note that although
preliminary given the small sample size, the study "shows that
issues concerning the relationship between the consumption of marijuana
and participation in a drug treatment
can be systematically evaluated. "
cannabis consumption among those using it for medicinal purposes
not seem to compromise a substance abuse treatment. I
was equal to or better than non-medical cannabis users
on the results of several important variables, such as
compliance and participation in the judicial system
. The authors concluded that their
pilot study suggests that the medical use of cannabis is compatible with the
participation in treatment programs for abandoning
drugs and does not adversely affect its results "and that" medical marijuana
may be justified in treating addictions
as a harm reduction tool. "
Item available in:
http://www.harmreductionjournal.com/content/pdf/1477-7517-7-
3.pdf (Source: Medical R. Swartz marijuana users in Substance Abuse Treatment
. Redoubt Harm J 2010, 7 (1): 3.)
2.
News Brief *** New Zealand: Medicinal use
According to a report by the Law Commission cannabis
should be allowed as medicine. The President of the Law Commission Sir Geoffrey Palmer
said Feb. 11 it had
'room for a wide range of different approaches "in
drug laws in New Zealand. The report says that "there
why cannabis should not be used to
medical purposes under certain circumstances."
Justice Minister Simon Power said he was interested in the report, but
not allow the use of cannabis. (Source: www.stuff.co.nz
February 11, 2010) ***
Netherlands: Schizophrenia
Scientists from the Universities of Utrecht and Maastricht
received 24 million euros (33 million American
U.S. dollars) of the European Union to investigate treatment options
schizophrenia. One of the five studies assessed the potential
benefits of natural cannabinoid cannabidiol (CBD). (Source: University of Utrecht
March 4, 2010, www.umcutrecht.nl )
*** Science: Psychosis
Australian researchers followed more than 3801
men and women born between 1981 and 1984 until after
of 21 years about their consumption of cannabis and assessed psychotic episodes
presented. About 18 percent said they used cannabis
for three years or less, 16 percent
four to five years and 14 percent for six or more years.
In their conclusion the authors note that "compared with those
who had never used cannabis,
young adults who had consumed cannabis
six or more years were twice as likely to develop non-affective psychosis
(like schizophrenia). "(Source: McGrath J, et al.
Arch Gen Psychiatry, 2010 Mar 1. [Electronic
print]) *** Science
: Addiction
According to a systematic review and meta-analysis of changes
involvement of CB1 receptors in the vulnerability of dependence
substances is only small. (Source: Benyamina
A, et al. Addict Biol, 2010 Feb 26. [Electronic
print]) *** Science
: Epilepsy
The natural cannabinoid delta-9-tetrahydrocannabivarin (delta-9-
THCV) reduces seizure activity in a model of epilepsy in rat
. (Source: Hill AJ, et al. Epilepsia, 2010 Feb 26.
[Electronic publication ahead of print])
International Association for Cannabinoid Medicines
(IACM)
Am
Mildenweg 6 D-59602 Ruether
Germany Phone: + 49 (0) 2952-9708571
Fax: +49 (0) 2952-902651 Email
: info@cannabis-med.org
http://www.cannabis-med.org
To join low or high on the list Mailing
Bulletin of the IACM, or if you change your email address, please visit
www.cannabis-med.org/spanish/subscribe.htm .
can choose different languages \u200b\u200b(English, German, French, Dutch, Italian and English
).
items taken from the Bulletin of the IACMbo
can be printed, translated and distributed freely for any purpose
noncommercial, provided the original work is properly cited
. The source of the Bulletin of the IACM is
"IACM, www.cannabis-med.org ."
IACM-Bulletin of 17 March 2010
-------------------------------- ------------------------
* Science: a pilot study, the medical use of cannabis
not affect the results of treatment for abuse
substance
1.
Science: a pilot study, the medical use of cannabis
not affect the results of treatment for substance abuse
has investigated the effects of medical use of cannabis in the
result of treatment for abuse of
substances in a pilot study conducted in California. Of the members,
raised a public program for substance abuse treatment in California
, 13 medical cannabis and 146 no.
all medical cannabis users were included in the
treatment program for substance abuse
judicial order and had received permission to use cannabis for therapeutic purposes
while in the program.
The researchers note that although
preliminary given the small sample size, the study "shows that
issues concerning the relationship between the consumption of marijuana
and participation in a drug treatment
can be systematically evaluated. "
cannabis consumption among those using it for medicinal purposes
not seem to compromise a substance abuse treatment. I
was equal to or better than non-medical cannabis users
on the results of several important variables, such as
compliance and participation in the judicial system
. The authors concluded that their
pilot study suggests that the medical use of cannabis is compatible with the
participation in treatment programs for abandoning
drugs and does not adversely affect its results "and that" medical marijuana
may be justified in treating addictions
as a harm reduction tool. "
Item available in:
http://www.harmreductionjournal.com/content/pdf/1477-7517-7-
3.pdf (Source: Medical R. Swartz marijuana users in Substance Abuse Treatment
. Redoubt Harm J 2010, 7 (1): 3.)
2.
News Brief *** New Zealand: Medicinal use
According to a report by the Law Commission cannabis
should be allowed as medicine. The President of the Law Commission Sir Geoffrey Palmer
said Feb. 11 it had
'room for a wide range of different approaches "in
drug laws in New Zealand. The report says that "there
why cannabis should not be used to
medical purposes under certain circumstances."
Justice Minister Simon Power said he was interested in the report, but
not allow the use of cannabis. (Source: www.stuff.co.nz
February 11, 2010) ***
Netherlands: Schizophrenia
Scientists from the Universities of Utrecht and Maastricht
received 24 million euros (33 million American
U.S. dollars) of the European Union to investigate treatment options
schizophrenia. One of the five studies assessed the potential
benefits of natural cannabinoid cannabidiol (CBD). (Source: University of Utrecht
March 4, 2010, www.umcutrecht.nl )
*** Science: Psychosis
Australian researchers followed more than 3801
men and women born between 1981 and 1984 until after
of 21 years about their consumption of cannabis and assessed psychotic episodes
presented. About 18 percent said they used cannabis
for three years or less, 16 percent
four to five years and 14 percent for six or more years.
In their conclusion the authors note that "compared with those
who had never used cannabis,
young adults who had consumed cannabis
six or more years were twice as likely to develop non-affective psychosis
(like schizophrenia). "(Source: McGrath J, et al.
Arch Gen Psychiatry, 2010 Mar 1. [Electronic
print]) *** Science
: Addiction
According to a systematic review and meta-analysis of changes
involvement of CB1 receptors in the vulnerability of dependence
substances is only small. (Source: Benyamina
A, et al. Addict Biol, 2010 Feb 26. [Electronic
print]) *** Science
: Epilepsy
The natural cannabinoid delta-9-tetrahydrocannabivarin (delta-9-
THCV) reduces seizure activity in a model of epilepsy in rat
. (Source: Hill AJ, et al. Epilepsia, 2010 Feb 26.
[Electronic publication ahead of print])
International Association for Cannabinoid Medicines
(IACM)
Am
Mildenweg 6 D-59602 Ruether
Germany Phone: + 49 (0) 2952-9708571
Fax: +49 (0) 2952-902651 Email
: info@cannabis-med.org
http://www.cannabis-med.org
To join low or high on the list Mailing
Bulletin of the IACM, or if you change your email address, please visit
www.cannabis-med.org/spanish/subscribe.htm .
can choose different languages \u200b\u200b(English, German, French, Dutch, Italian and English
).
items taken from the Bulletin of the IACMbo
can be printed, translated and distributed freely for any purpose
noncommercial, provided the original work is properly cited
. The source of the Bulletin of the IACM is
"IACM, www.cannabis-med.org ."
All comments are owned by the authors, the gang is not responsible for the minds of mothers and demands that may cause the comments made ... LosMejoresCuates Copyright 2005-2006 
0 comments:
Post a Comment